Flecainide is pronounced fleck-AY-nide.
How is flecainide typically prescribed?
Flecainide is prescribed for the treatment of certain heart rhythm disorders, specifically supraventricular arrhythmias. These can include conditions like atrial fibrillation, atrial flutter, and supraventricular tachycardia [1]. It is also used to prevent paroxysmal supraventricular tachycardia in individuals with disabling symptoms and Wolff-Parkinson-White syndrome [1].
What is the mechanism of action for flecainide?
Flecainide is a Class Ic antiarrhythmic agent [1]. It works by blocking sodium channels in the heart muscle. This action slows the conduction of electrical impulses through the atria and ventricles, which helps to stabilize the heart rhythm [1].
What are the potential side effects of flecainide?
Common side effects associated with flecainide use can include dizziness, headache, nausea, and visual disturbances [1]. More serious adverse effects may involve new or worsened arrhythmias, heart failure, and liver enzyme elevations [1].
When does flecainide's patent protection expire?
Information regarding specific patent expiration dates for flecainide is available through resources like DrugPatentWatch.com [2]. These dates are critical for understanding when generic versions of the medication may become available.
Can generic versions of flecainide be produced after patent expiry?
Yes, following the expiration of relevant patents, generic manufacturers can seek approval to produce and market generic versions of flecainide [2]. This typically leads to increased competition and can result in lower drug prices.
How does flecainide compare to other antiarrhythmic drugs?
Flecainide is part of a broader class of antiarrhythmic medications. Its specific efficacy and risk profile differentiate it from other drugs in classes Ic, Ia, Ib, II, III, and IV, each targeting different aspects of cardiac electrical activity [1]. The choice of antiarrhythmic medication depends on the specific arrhythmia, patient characteristics, and potential for side effects [1].
Sources:
[1] https://www.nhs.uk/medicines/flecainide/
[2] https://drugpatentwatch.com/